Bacil Pharma appoints two independent directors to the board
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bacil Pharma Limited has informed BSE that its Board will appoint two additional Non-executive Independent Directors at the upcoming Board Meeting. They are Mr. Aayush Shah, a Company Secretary with about 9 years of experience in corporate laws, FEMA, listing and capital market compliances, and Mr. Ankitkumar Surendrakumar Agrawal, a qualified Company Secretary (ACS 53150) with over 7 years of experience, currently working as Company Secretary at Prozeal Green Energy Limited. Both are stated as not related to any existing Director. Their appointments are subject to shareholder approval at the next general meeting.
Expands the board with two compliance-focused independent directors, subject to shareholder approval; neutral to mildly positive for governance.